Deferred Tax Assets, Valuation Allowance of Vaxart, Inc. from 30 Jun 2012 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Vaxart, Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 30 Jun 2012 to 31 Dec 2025.
  • Vaxart, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2025 was $100,494,000, a 6.8% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Vaxart, Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $100,494,000 +$6,375,000 +6.8% 31 Dec 2025 10-K 13 Mar 2026 2025 FY
Q4 2024 $94,119,000 +$11,619,000 +14% 31 Dec 2024 10-K 13 Mar 2026 2025 FY
Q4 2023 $82,500,000 +$16,177,000 +24% 31 Dec 2023 10-K 20 Mar 2025 2024 FY
Q4 2022 $66,323,000 +$23,734,000 +56% 31 Dec 2022 10-K 14 Mar 2024 2023 FY
Q4 2021 $42,589,000 +$20,637,000 +94% 31 Dec 2021 10-K 15 Mar 2023 2022 FY
Q4 2020 $21,952,000 +$8,587,000 +64% 31 Dec 2020 10-K 24 Feb 2022 2021 FY
Q4 2019 $13,365,000 -$35,261,000 -73% 31 Dec 2019 10-K 24 Feb 2022 2021 FY
Q4 2018 $48,626,000 +$25,662,000 +112% 31 Dec 2018 10-K 25 Feb 2021 2020 FY
Q4 2017 $22,964,000 31 Dec 2017 10-K 06 Feb 2019 2018 FY
Q2 2017 $44,400,000 +$8,200,000 +23% 30 Jun 2017 10-K 01 Sep 2017 2017 FY
Q2 2016 $36,200,000 +$9,100,000 +34% 30 Jun 2016 10-K 01 Sep 2017 2017 FY
Q2 2015 $27,100,000 +$700,000 +2.7% 30 Jun 2015 10-K 13 Sep 2016 2016 FY
Q2 2014 $26,400,000 +$5,000,000 +23% 30 Jun 2014 10-K 11 Sep 2015 2015 FY
Q2 2013 $21,400,000 +$300,000 +1.4% 30 Jun 2013 10-K 30 Sep 2014 2014 FY
Q2 2012 $21,100,000 30 Jun 2012 10-K 27 Sep 2013 2013 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.